Glycosylation as a key parameter in the design of nucleic acid vaccines
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycosylation as a key parameter in the design of nucleic acid vaccines
Authors
Keywords
-
Journal
CURRENT OPINION IN STRUCTURAL BIOLOGY
Volume 73, Issue -, Pages 102348
Publisher
Elsevier BV
Online
2022-03-05
DOI
10.1016/j.sbi.2022.102348
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A cross-neutralizing antibody between HIV-1 and influenza virus
- (2021) Chang-Chun D. Lee et al. PLoS Pathogens
- Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021
- (2021) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Recent developments and strategies of Ebola virus vaccines
- (2021) Ashish Ranjan Sharma et al. CURRENT OPINION IN PHARMACOLOGY
- Immune Responses to Viral Gene Therapy Vectors
- (2020) Jamie L. Shirley et al. MOLECULAR THERAPY
- Host protein glycosylation in nucleic acid vaccines as a potential hurdle in vaccine design for nonviral pathogens
- (2020) Ahmet Ozdilek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Site-specific glycan analysis of the SARS-CoV-2 spike
- (2020) Yasunori Watanabe et al. SCIENCE
- Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help
- (2020) Lina Sun et al. Nature Communications
- Sialyl-LewisX Glycoantigen Is Enriched on Cells with Persistent HIV Transcription during Therapy
- (2020) Florent Colomb et al. Cell Reports
- Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
- (2020) Peng Zhao et al. Cell Host & Microbe
- Self-amplifying RNA vaccines for infectious diseases
- (2020) Kristie Bloom et al. GENE THERAPY
- Visualization of the HIV-1 Env glycan shield across scales
- (2020) Zachary T. Berndsen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interferon-α alters host glycosylation machinery during treated HIV infection
- (2020) Leila B. Giron et al. EBioMedicine
- The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines
- (2020) Daan J.A. Crommelin et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Exploitation of glycosylation in enveloped virus pathobiology
- (2019) Yasunori Watanabe et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Glycoconjugates: What It Would Take To Master These Well-Known yet Little-Understood Immunogens for Vaccine Development
- (2019) Fikri Avci et al. mSphere
- Structure and Immune Recognition of the HIV Glycan Shield
- (2018) Max Crispin et al. Annual Review of Biophysics
- Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture
- (2018) Daniela S. Rajão et al. Frontiers in Microbiology
- Engineering DNA vaccines against infectious diseases
- (2018) Jihui Lee et al. Acta Biomaterialia
- Metabolic labeling of HIV-1 envelope glycoprotein gp120 to elucidate the effect of gp120 glycosylation on antigen uptake
- (2018) Lina Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glycans as Key Checkpoints of T Cell Activity and Function
- (2018) Márcia S. Pereira et al. Frontiers in Immunology
- Glycan–protein interactions in viral pathogenesis
- (2016) Rahul Raman et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Carbohydrates as T-cell antigens with implications in health and disease
- (2016) Lina Sun et al. GLYCOBIOLOGY
- Biological roles of glycans
- (2016) Ajit Varki GLYCOBIOLOGY
- Thetrans-sialidase, the majorTrypanosoma cruzivirulence factor: Three decades of studies
- (2015) L Freire-de-Lima et al. GLYCOBIOLOGY
- A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants
- (2015) M. Tameris et al. VACCINE
- Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial
- (2015) Birahim Pierre Ndiaye et al. Lancet Respiratory Medicine
- Vaccines for the 21st century
- (2014) I. Delany et al. EMBO Molecular Medicine
- The interplay between Siglecs and sialylated pathogens
- (2014) Y.-C. Chang et al. GLYCOBIOLOGY
- Novel Strategies for Development of Next-Generation Glycoconjugate Vaccines
- (2013) Fikri Avci CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Glycosylation of Serum Proteins in Inflammatory Diseases
- (2013) Olga Gornik et al. DISEASE MARKERS
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
- (2013) Jason E Hudak et al. Nature Chemical Biology
- O-mannosylation of the Mycobacterium tuberculosis Adhesin Apa Is Crucial for T Cell Antigenicity during Infection but Is Expendable for Protection
- (2013) Subhadra Nandakumar et al. PLoS Pathogens
- Siglecs as sensors of self in innate and adaptive immune responses
- (2012) James C. Paulson et al. Annals of the New York Academy of Sciences
- Sialoglycoproteins adsorbed by Pseudomonas aeruginosa facilitate their survival by impeding neutrophil extracellular trap through siglec-9
- (2012) B. Khatua et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Vertebrate protein glycosylation: diversity, synthesis and function
- (2012) Kelley W. Moremen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Campylobacter Polysaccharide Capsules: Virulence and Vaccines
- (2012) Patricia Guerry et al. Frontiers in Cellular and Infection Microbiology
- Letter to the Glyco-Forum: Since there are PAMPs and DAMPs, there must be SAMPs? Glycan "self-associated molecular patterns" dampen innate immunity, but pathogens can mimic them
- (2011) A. Varki GLYCOBIOLOGY
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
- (2011) Jason S. McLellan et al. NATURE
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
- (2011) R. Pejchal et al. SCIENCE
- Capsules ofStreptococcus pneumoniaeand Other Bacteria: Paradigms for Polysaccharide Biosynthesis and Regulation
- (2010) Janet Yother Annual Review of Microbiology
- Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response
- (2009) A. F. Carlin et al. BLOOD
- Viruses as vaccine vectors for infectious diseases and cancer
- (2009) Simon J. Draper et al. NATURE REVIEWS MICROBIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now